Author:
Cao Xu,Li Qingwei,Lu Xiwei,Lu Jiali,Song Xiaoping,Han Yinglun,Li Jun,Zhao Zhisheng,Pu Chunwen,Pang Yue
Reference31 articles.
1. Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management;H Samant;Journal of gastrointestinal oncology,2021
2. Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B;D Ji;J Hepatol,2022
3. Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?;N D Parikh;J Hepatol,2022
4. Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitis;K Ogawa;Scientific reports,2020
5. Glycan analysis of colorectal cancer samples reveals stagedependent changes in CEA glycosylation patterns;Q Zhao;Clinical proteomics,2018